Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

Name: Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
Published: 2018
License: Public Domain

M.D. Anderson Cancer Center · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

renal-cell-carcinoma

malignant neoplasms of urinary tract, renal cell carcinoma, chromophobe renal cell carcinoma, metastatic renal cell carcinoma, papillary renal cell carcinoma, renal cell carcinoma associated with xp11.2 translocations/tfe3 gene fusions, sarcomatoid renal cell carcinoma, stage iv renal cell cancer ajcc v8, unclassified renal cell carcinoma, cabozantinib, xl-184, xl184

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 907275
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.